Clinical Trial Update: Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigates fruquintinib in combination with SOX as neoadjuvant therapy for locally advanced gastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)
• SOX (SOX)

Snippet

Sponsor: Guangxi Medical University | Conditions: Gastric Cancer, GastroEsophageal Cancer | Phase 2 | Status: UNKNOWN